Navigation Links
Karolinska Development Introduces New Concept for Development of its Dermatology and Wound Healing Portfolio

STOCKHOLM, September 9 /PRNewswire/ -- Karolinska Development (publ) have announced the formation of Pergamum AB, a company that will commercialize its dermatology and wound healing opportunities as associated business units within one company. Karolinska Development has transferred all of its holdings from its five dermatology and wound healing companies to Pergamum AB, owning 64% of the new company.

"This is a new initiative from Karolinska Development as part of our overall strategy to maximize value appreciation within our portfolio," stated Conny Bogentoft, CEO of Karolinska Development. "We have an exciting group of technologies in this area and we expect the new corporate structure to both reduce costs and speed up development times. It also offers considerable advantages when seeking exit opportunities. Pergamum will be able to represent several or all of the development projects when discussing sales or licensing opportunities with pharma companies. We are not aware of any other similar situation within the industry," added Dr Bogentoft.

Pergamum's development projects currently cover improved wound healing and reduced scar formation, healing hard-to-heal-wounds, the prevention of bacterial and fungal infections, atopic dermatitis and infected wounds and burns.

Magnus Precht, CEO of Pergamum AB, said, "There is a good balance across the business units and we already have three projects undergoing clinical trials. What makes Pergamum different is that we provide each of our individual businesses with access to technical skills and key competencies in an extremely resource-efficient way. This is something that other companies at similar stages of development simply cannot do. In addition, by focusing on related fields we are able to continually acquire and share specialist knowledge that will benefit development over the long term."

Pergamum CEO Magnus Precht will present Pergamum at the Rodman & Renshaw Annual Global Investment Conference in New York September 9-11, 2009 and will be available for one-on-one meetings with investors and potential partners during the conference.

Pergamum's other two owners are Ostersjostiftelsen (The Foundation for Baltic and East European Studies) and Midroc New Technology.

About Karolinska Development:

Managing one of the largest portfolios of life science research companies in Europe, Karolinska Development

AB is a new type of company focused on filling the innovation gap within the pharmaceutical industry. Using a unique, highly cost-effective model Karolinska Development commercializes internationally renowned life science innovations, helping to deliver the medical products of the future.

    For more information please contact:

    Conny Bogentoft, CEO, Karolinska Development AB
    Cell phone +46-70-668-61-43

    Magnus Precht, CEO, Pergamum AB
    European mobile phone: +46-73-515-7450
    US cell phone: +1-817-312-7277

SOURCE Karolinska Development AB
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD
2. Karolinska Development Invests in EvoStem Finland Oy
3. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
4. The Feinstein to collaborate with Swedens Karolinska Institute
5. 3 new honorary doctors at Karolinska Institutet
6. Karolinska Institutets Pedersen to receive GSAs 2007 Distinguished Career Award
7. Special Autism Issue Published by the College of Optometrists in Vision Development
8. Cepheid Announces Accelerated Development of Flu A Panel Test
9. GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
10. Vaxart Awarded NIH Grant to Support Development of Orally-Delivered H5N1 Avian Influenza Vaccine
11. Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Dr. Poneh Ghasri, ... Today on September 18, 2015. The research, which was conducted at the Dental Institute ... and colleagues, show connections between stress during pregnancy and future dental health in the ...
(Date:10/13/2015)... ... October 13, 2015 , ... Leading Internet marketing ... launched "Publish Academy" training course . Singal's new program, in which he ... and marketers around the Internet are weighing in with reviews. , "Considering the ...
(Date:10/13/2015)... ... , ... Scientists in Seattle and Vancouver compared the diagnostic value of lung ... Surviving Mesothelioma has just posted an article on the new research. Click here ... the University of British Columbia found that certain genetic alterations were seen just as ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... School of Nursing. Dr. McLeod—who earned her Doctor of Nursing Practice from the ... that has spanned four decades. , Dr. McLeod’s long and successful nursing practice ...
(Date:10/13/2015)... ... 13, 2015 , ... Breathing is one of the human ... According to T’ai Chi (also spelled “Taiji”) and Qigong Grand-masters Steven Aung, MD, ... with the 7,000 year old tradition they teach, can improve health, increase energy ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... Oct. 13, 2015   Rosa & Co. LLC ... Quantitative Systems Pharmacology (QSP)/ PhysioPD™ , today announced that ... a workshop at the QSP Congress Meeting ... Boston, MA.  The conference focuses on the ...  Dr. Friedrich,s workshop is entitled "Using Mechanistic Physiological Models ...
(Date:10/13/2015)... , Oct. 13, 2015 China ... or " China Jo-Jo "), a leading China-based retail, ... products through its own online and retail pharmacies, announced ... Company,s official branded online pharmacy through , ... was a record 25%. China Jo-Jo,s ...
(Date:10/13/2015)... 13, 2015  Yesterday Congresswoman Renee Ellmers ... manufacturing site located in Holly Springs, NC ... produced Flucelvax ® (Influenza Vaccine) using cell-culture technology, a ... start-up and is not reliant on chicken eggs. 1,2 ... influenza vaccines business of Novartis AG in the US, ...
Breaking Medicine Technology: